Literature DB >> 31539062

MicroRNAs as non-invasive biomarkers of renal disease.

Katie L Connor1, Laura Denby1.   

Abstract

Entities:  

Year:  2021        PMID： 31539062      PMCID： PMC7898020          DOI： 10.1093/ndt/gfz183

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  10 in total

1.  Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.

Authors:  Grazia Serino; Fabio Sallustio; Sharon N Cox; Francesco Pesce; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

2.  Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.

Authors:  Sungjin Park; SeongRyeol Moon; Kiyoung Lee; Ie Byung Park; Dae Ho Lee; Seungyoon Nam
Journal:  Cell Physiol Biochem       Date:  2018-04-18

Review 3.  MicroRNAs in kidney physiology and disease.

Authors:  Piera Trionfini; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-11-11       Impact factor: 28.314

4.  In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.

Authors:  Grazia Serino; Francesco Pesce; Fabio Sallustio; Giuseppe De Palma; Sharon N Cox; Claudia Curci; Gianluigi Zaza; Kar N Lai; Joseph C K Leung; Sydney C W Tang; Aikaterini Papagianni; Maria Stangou; Dimitrios Goumenos; Miltiadis Gerolymos; Kazuo Takahashi; Yukio Yuzawa; Shoichi Maruyama; Enyu Imai; Francesco P Schena
Journal:  Kidney Int       Date:  2016-03       Impact factor: 10.612

Review 5.  Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Authors:  Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

6.  Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.

Authors:  Ophélie Fourdinier; Eva Schepers; Valérie Metzinger-Le Meuth; Griet Glorieux; Sophie Liabeuf; Francis Verbeke; Raymond Vanholder; Benjamin Brigant; Anneleen Pletinck; Momar Diouf; Stéphane Burtey; Gabriel Choukroun; Ziad A Massy; Laurent Metzinger
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis.

Authors:  Qiulun Lu; Zejun Ma; Ye Ding; Tatiana Bedarida; Liming Chen; Zhonglin Xie; Ping Song; Ming-Hui Zou
Journal:  Nat Commun       Date:  2019-05-13       Impact factor: 14.919

8.  A urinary microRNA panel that is an early predictive biomarker of delayed graft function following kidney transplantation.

Authors:  Usman Khalid; Lucy J Newbury; Kate Simpson; Robert H Jenkins; Timothy Bowen; Lucy Bates; Neil S Sheerin; Rafael Chavez; Donald J Fraser
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

9.  Normalization strategies differently affect circulating miRNA profile associated with the training status.

Authors:  Martina Faraldi; Marta Gomarasca; Veronica Sansoni; Silvia Perego; Giuseppe Banfi; Giovanni Lombardi
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

10.  MicroRNA-21 and risk of severe acute kidney injury and poor outcomes after adult cardiac surgery.

Authors:  Juan Du; Xiaoqing Cao; Liang Zou; Yi Chen; Jin Guo; Zujun Chen; Shengshou Hu; Zhe Zheng
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240
  10 in total
  8 in total

Review 1.  The Role of MicroRNA in Contrast-Induced Nephropathy: A Scoping Review and Meta-Analysis.

Authors:  Mangiring P L Toruan; Raymond Pranata; Budi Yuli Setianto; Sofia Mubarika Haryana
Journal:  Biomed Res Int       Date:  2020-05-21       Impact factor: 3.411

Review 2.  MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.

Authors:  Linsey J F Peters; Jürgen Floege; Erik A L Biessen; Joachim Jankowski; Emiel P C van der Vorst
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

3.  Identifying cell-enriched miRNAs in kidney injury and repair.

Authors:  Katie L Connor; Oliver Teenan; Carolynn Cairns; Victoria Banwell; Rachel Ab Thomas; Julie Rodor; Sarah Finnie; Riinu Pius; Gillian M Tannahill; Vishal Sahni; Caroline Os Savage; Jeremy Hughes; Ewen M Harrison; Robert B Henderson; Lorna P Marson; Bryan R Conway; Stephen J Wigmore; Laura Denby
Journal:  JCI Insight       Date:  2020-12-17

4.  Renal Tissue miRNA Expression Profiles in ANCA-Associated Vasculitis-A Comparative Analysis.

Authors:  Matic Bošnjak; Željka Večerić-Haler; Emanuela Boštjančič; Nika Kojc
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

5.  Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer Aggressiveness.

Authors:  Elena Arance; Viviana Ramírez; Alejandro Rubio-Roldan; Francisco M Ocaña-Peinado; Catalina Romero-Cachinero; Ana Belén Jódar-Reyes; Fernando Vazquez-Alonso; Luis Javier Martinez-Gonzalez; Maria Jesus Alvarez-Cubero
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

6.  Evaluation of endogenous miRNA reference genes across different zebrafish strains, developmental stages and kidney disease models.

Authors:  Florian Siegerist; Tim Lange; Anna Iervolino; Thor Magnus Koppe; Weibin Zhou; Giovambattista Capasso; Karlhans Endlich; Nicole Endlich
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

7.  Current findings of kidney biopsy including nephropathy associated with hypertension and diabetes mellitus in Korea.

Authors:  Kipyo Kim; Sang Ho Lee; Sung Woo Lee; Jung Pyo Lee; Ho Jun Chin
Journal:  Korean J Intern Med       Date:  2020-08-14       Impact factor: 2.884

Review 8.  miRNA biomarkers in renal disease.

Authors:  Beata Franczyk; Anna Gluba-Brzózka; Robert Olszewski; Magdalena Parolczyk; Magdalena Rysz-Górzyńska; Jacek Rysz
Journal:  Int Urol Nephrol       Date:  2021-07-06       Impact factor: 2.370
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.